Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma net income
Net income is the profit left for shareholders after every expense, interest and tax.
Sunshine Biopharma's net income for the twelve months ending Jun 30, 2026 was -$5.83M. For fiscal 2025 it was -$5.98M. The highest annual figure on record is -$537.38K in fiscal 2010.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.98M | – |
| FY2024 | Dec 31, 2024 | -$5.13M | – |
| FY2023 | Dec 31, 2023 | -$4.51M | – |
| FY2022 | Dec 31, 2022 | -$26.74M | – |
| FY2021 | Dec 31, 2021 | -$12.44M | – |
| FY2020 | Dec 31, 2020 | -$2.78M | – |
| FY2019 | Dec 31, 2019 | -$1.66M | – |
| FY2018 | Dec 31, 2018 | -$2.16M | – |
| FY2017 | Dec 31, 2017 | -$1.04M | – |
| FY2016 | Dec 31, 2016 | -$3.50M | – |
| FY2015 | Dec 31, 2015 | -$1.65M | – |
| FY2014 | Dec 31, 2014 | -$1.93M | – |
| FY2013 | Dec 31, 2013 | -$2.49M | – |
| FY2012 | Dec 31, 2012 | -$707.95K | – |
| FY2011 | Dec 31, 2011 | -$556.20K | – |
| FY2010 | Dec 31, 2010 | -$537.38K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.56M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.14M | – |
| Q3 FY2025 | Sep 30, 2025 | -$883.82K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.77M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.18M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.16M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$494.30K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.28M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.25M | – |
| Q3 FY2023 | Sep 30, 2023 | -$651.48K | – |
| Q2 FY2023 | Jun 30, 2023 | -$902.11K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.70M | – |
| Q4 FY2022 | Dec 31, 2022 | -$23.51M | -3624.5% |
| Q3 FY2022 | Sep 30, 2022 | -$1.46M | – |
| Q2 FY2022 | Jun 30, 2022 | -$538.87K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.24M | – |
| Q4 FY2021 | Dec 31, 2021 | $667.12K | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.04M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.88M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.19M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.08M | – |
| Q3 FY2020 | Sep 30, 2020 | -$698.60K | – |
| Q2 FY2020 | Jun 30, 2020 | -$907.44K | – |
| Q1 FY2020 | Mar 31, 2020 | -$94.26K | – |
| Q4 FY2019 | Dec 31, 2019 | -$396.62K | – |
| Q3 FY2019 | Sep 30, 2019 | -$350.24K | – |
| Q2 FY2019 | Jun 30, 2019 | -$710.89K | – |
| Q1 FY2019 | Mar 31, 2019 | -$202.54K | – |
| Q4 FY2018 | Dec 31, 2018 | -$338.66K | – |
| Q3 FY2018 | Sep 30, 2018 | -$907.56K | – |
| Q2 FY2018 | Jun 30, 2018 | -$644.31K | – |
| Q1 FY2018 | Mar 31, 2018 | -$265.64K | – |
| Q4 FY2017 | Dec 31, 2017 | -$211.48K | – |
| Q3 FY2017 | Sep 30, 2017 | -$147.61K | – |
| Q2 FY2017 | Jun 30, 2017 | -$485.44K | – |
| Q1 FY2017 | Mar 31, 2017 | -$195.70K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.12M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.59M | – |